The Label · The Season, Not the Day
This name holds its accumulation label.
Jyong Biotech Ltd holds its Accumulation at $2.26. Consolidating, no directional conviction, held for 92 days.
As held on the ledger · 2025-12-31
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 92 days |
| Price at the screen | $2.26 |
| Valuation | N/A trailing · N/A forward price to earnings |
| Values screen | FAIL · score 70.0 |
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|
| Business activity |
Permissible |
Core business clean |
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. |
Pass |
| Debt load |
89.27% |
Below 33% |
Interest-bearing debt is 89.3% of its assets, above the one-third ceiling the screen allows. |
Fail |
| Interest-bearing cash |
0.00% |
Below 33% |
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. |
Pass |
| Receivables |
70.68% |
Below 49% |
Money owed to the company is 70.7% of assets, above the 49% limit. |
Fail |
| Revenue purity |
Excluded |
Below 5% |
of revenue comes from non-compliant sources, over the 5% line. |
Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words
The fundamentals · plain-English read
| EPS, trailing | -0.06 |
| Profit margin | 0.0%currently unprofitable |
| FCF yield | 2.55% |
| Current ratio | 0.45below 1: short-term bills exceed liquid assets |
| Short interest, float | 0.01% |
| 52-week range | 1.43 - 67.00 |
| Moat | NONE |
| Market cap | $172M |
| Employees | 27 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Taiwan and to currency swings; as a biotechnology name, trial and regulatory outcomes can move it sharply either way.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MENS trades on NASDAQ (the company is based in Taiwan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.